To examine the influence of RPL10 ufmylation on tumorigenesis, pancreatic cancer cells with stable knockdown of UFL1 were implanted in immune-deficient mice to evaluate tumor growth. This evidence concerns the gene RPL10 and pancreatic neoplasm.